2.Glycosphingolipid-mediated apoptosis and tumor therapy: a review.
Mengqi YIN ; Jiajun YANG ; Hanjie YU ; Zheng LI
Chinese Journal of Biotechnology 2022;38(10):3659-3673
Glycosphingolipids (GSLs) are widely distributed in the phospholipid bilayer of various cell membranes, which play an important role in maintaining cell membrane stability, and regulate various cellular processes including adhesion, proliferation, apoptosis and recognition, as well as participate in various cellular activities. In addition, GSLs are not only involved in the process of apoptosis, but also regulate multiple signals in tumorigenesis and tumor development. The tumor-associated GSLs are expected to be used as diagnostic markers and immunotherapeutic targets for malignant tumors. These findings have important implications for the study of apoptosis and provide the new direction of tumor therapy. This review summarized the latest research progress of GSLs-mediated apoptosis and its effect on the genesis, development and metastasis of tumor cells. Moreover, we discussed the metabolic pathway of GSLs-mediated apoptosis and its application in tumor therapy, as well as the development prospect of targeted therapy strategies based on GSLs.
Humans
;
Glycosphingolipids/metabolism*
;
Apoptosis
;
Cell Membrane
;
Neoplasms/metabolism*
3.Updates on clinicopathologic findings of Niemann-Pick disease type C.
Ying TANG ; Wei LIU ; Jun-ping LIU
Chinese Journal of Pathology 2010;39(5):356-360
Animals
;
Brain
;
metabolism
;
pathology
;
Calcium
;
metabolism
;
Cholesterol
;
metabolism
;
Glycosphingolipids
;
metabolism
;
Humans
;
Liver
;
pathology
;
Neurons
;
metabolism
;
pathology
;
Niemann-Pick Disease, Type C
;
diagnosis
;
etiology
;
metabolism
;
pathology
;
Sphingosine
;
metabolism
4.A Case of Renal Transplantation in A Patient with Fabry's Disease.
Won KIM ; Hyeon Woo KOH ; Sung Kwang PARK ; Sung Kyew KANG ; Seung Ryel RHEE ; Hee Chul YU ; Baik Hwan CHO ; Min Chul KIM ; Kwang Young LEE
The Journal of the Korean Society for Transplantation 1998;12(1):111-116
Fabry's disease is a rare, inborn error, sex-linked disorder of glycosphingolipid metabolism with death occurring from myocardial or renal involvement at 4th or 5th decades. The primary metabolic defect lies in the deficient tissue activity of the enzyme alpha-galactosidase A which results in progressive accumulation of the specific neutral glycosphingolipids, cerebroside dihexoside(CDH) and cerebroside triihexoside(CTH), within the lysosomes of endothelial, perithelial and smooth muscle cells of the cardiovascular and renal systems predominantly. Clinical manifestations are sequelae of the anatomic and physiologic alterations produced by the progressive deposition of glycosphingolipid in the tissues. We report the first case of successful renal transplantation in a patient with Fabry's disease in Korea. The patient was a 33-year-old male. Fabry's disease was confirmed by measurement of serum alpha- galactosidase level and renal biopsy. Biopsy finding showed lamellar inclusion bodies on electron microscopy. Galactosidase activity was also markedly decreased. He has been well for 49 months.
Adult
;
alpha-Galactosidase
;
Biopsy
;
Fabry Disease*
;
Galactosidases
;
Humans
;
Inclusion Bodies
;
Kidney Transplantation*
;
Korea
;
Lysosomes
;
Male
;
Metabolism
;
Microscopy, Electron
;
Myocytes, Smooth Muscle
;
Neutral Glycosphingolipids
;
Transplantation
5.A Case of Renal Transplantation in A Patient with Fabry's Disease.
Won KIM ; Hyeon Woo KOH ; Sung Kwang PARK ; Sung Kyew KANG ; Seung Ryel RHEE ; Hee Chul YU ; Baik Hwan CHO ; Min Chul KIM ; Kwang Young LEE
The Journal of the Korean Society for Transplantation 1998;12(1):111-116
Fabry's disease is a rare, inborn error, sex-linked disorder of glycosphingolipid metabolism with death occurring from myocardial or renal involvement at 4th or 5th decades. The primary metabolic defect lies in the deficient tissue activity of the enzyme alpha-galactosidase A which results in progressive accumulation of the specific neutral glycosphingolipids, cerebroside dihexoside(CDH) and cerebroside triihexoside(CTH), within the lysosomes of endothelial, perithelial and smooth muscle cells of the cardiovascular and renal systems predominantly. Clinical manifestations are sequelae of the anatomic and physiologic alterations produced by the progressive deposition of glycosphingolipid in the tissues. We report the first case of successful renal transplantation in a patient with Fabry's disease in Korea. The patient was a 33-year-old male. Fabry's disease was confirmed by measurement of serum alpha- galactosidase level and renal biopsy. Biopsy finding showed lamellar inclusion bodies on electron microscopy. Galactosidase activity was also markedly decreased. He has been well for 49 months.
Adult
;
alpha-Galactosidase
;
Biopsy
;
Fabry Disease*
;
Galactosidases
;
Humans
;
Inclusion Bodies
;
Kidney Transplantation*
;
Korea
;
Lysosomes
;
Male
;
Metabolism
;
Microscopy, Electron
;
Myocytes, Smooth Muscle
;
Neutral Glycosphingolipids
;
Transplantation
6.The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells.
Ji Ung JUNG ; Kinarm KO ; Dae Hoon LEE ; Kisung KO ; Kyu Tae CHANG ; Young Kug CHOO
Experimental & Molecular Medicine 2009;41(12):935-945
Glycosphingolipids including gangliosides play important regulatory roles in cell proliferation and differentiation. UDP-glucose:ceramide glucosyltransferase (Ugcg) catalyze the initial step in glycosphingolipids biosynthesis pathway. In this study, Ugcg expression was reduced to approximately 80% by short hairpin RNAs (shRNAs) to evaluate the roles of glycosphingolipids in proliferation and neural differentiation of mouse embryonic stem cells (mESCs). HPTLC/immunofluorescence analyses of shRNA-transfected mESCs revealed that treatment with Ugcg-shRNA decreased expression of major gangliosides, GM3 and GD3. Furthermore, MTT and Western blot/immunofluorescence analyses demonstrated that inhibition of the Ugcg expression in mESCs resulted in decrease of cell proliferation (P < 0.05) and decrease of activation of the ERK1/2 (P < 0.05), respectively. To further investigate the role of glycosphingolipids in neural differentiation, the embryoid bodies formed from Ugcg-shRNA transfected mESCs were differentiated into neural cells by treatment with retinoic acid. We found that inhibition of Ugcg expression did not affect embryoid body (EB) differentiation, as judged by morphological comparison and expression of early neural precursor cell marker, nestin, in differentiated EBs. However, RT-PCR/immunofluorescence analyses showed that expression of microtubule- associated protein 2 (MAP-2) for neurons and glial fibrillary acidic protein (GFAP) for glial cells was decreased in neural cells differentiated from the shRNA-transfected mESCs. These results suggest that glycosphingolipids are involved in the proliferation of mESCs through ERK1/2 activation, and that glycosphingolipids play roles in differentiation of neural precursor cells derived from mESCs.
Animals
;
*Cell Proliferation
;
Cells, Cultured
;
Down-Regulation
;
Embryonic Stem Cells/*cytology/metabolism
;
Glucosyltransferases/genetics/metabolism
;
Glycosphingolipids/genetics/*metabolism
;
Mice
;
Mitogen-Activated Protein Kinases/metabolism
;
*Neurogenesis
;
Neurons/*cytology/metabolism
;
RNA, Messenger/genetics
7.Production of nitric oxide by murine macrophages induced by lipophosphoglycan of Leishmania major.
Gholamreza KAVOOSI ; Sussan K ARDESTANI ; Amina KARIMINIA ; Zahra TAVAKOLI
The Korean Journal of Parasitology 2006;44(1):35-41
Protozoan parasites of the genus Leishmania cause a number of important human diseases. One of the key determinants of parasite infectivity and survival is the surface glycoconjugate lipophosphoglycan (LPG). In addition, LPG is shown to be useful as a transmission blocking vaccine. Since culture supernatant of parasite promastigotes is a good source of LPG, we made attempts to characterize functions of the culture supernatant, and membrane LPG isolated from metacyclic promastigotes of Leishmania major. The purification scheme included anion-exchange chromatography, hydrophobic interaction chromatography and cold methanol precipitation. The purity of supernatant LPG (sLPG) and membrane LPG (mLPG) was determined by SDS-PAGE and thin layer chromatography. The effect of mLPG and sLPG on nitric oxide (NO) production by murine macrophages cell line (J774.1A) was studied. Both sLPG and mLPG induced NO production in a dose dependent manner but sLPG induced significantly higher amount of NO than mLPG. Our results show that sLPG is able to promote NO production by murine macrophages.
Nitric Oxide/analysis/*biosynthesis
;
Mice, Inbred BALB C
;
Mice
;
Macrophages/*drug effects/metabolism/parasitology
;
Leishmania major/chemistry/pathogenicity/*physiology
;
Glycosphingolipids/isolation & purification/*pharmacology
;
Endotoxins/analysis
;
Electrophoresis, Polyacrylamide Gel
;
Culture Media
;
Chromatography, Thin Layer/methods
;
Cell Membrane/chemistry
;
Cell Line
;
Animals
8.A Case of Fabry Disease, Following Renal Biopsy for the Investigation of Proteinuria.
Jae Uk OK ; Ki Hyun CHOI ; Jane OH ; Kun Ho KWON ; Dong Ho YANG ; Kyung Soo KIM ; Yong Hee LEE
Korean Journal of Nephrology 2001;20(6):1053-1057
Fabry disease, angiokeratoma corporis diffusum, is a rare X-linked inborn error of glycosphingolipid metabolism due to the lack of the lysosomal enzyme, alpha-galactosidase A, resulting in a progressive deposition of specific neutral glycosphingolipids within the lysosomes of endothelial and smooth muscle cells of the cardiovascular and renal systems predominantly. We reported a case of Fabry disease, following renal biopsy for the investigation of proteinuria(Creatinine clearance 87.28 mL/min/1.73, serum creatinine 1.1 mg/dL, 24-hour urine protein 1,125 mg, 24-hour urine creatinine 1,382 mg). The patient was 46 year old male. He had experienced anterior chest pain regarded as angina pectoris for a few years. A 12- lead electrocardiogram was abnormal(T-wave inversion in II, III, AVF, and V3-V6), but echocardiography and coronary angiography revealed no abnormal. Kidney biopsy findings showed lamella inclusion bodies on electron microscopy, which are typical finding of Fabry disease. The patient is followed at O.P.D without any significant complaints for 18 months after diagnosis of Fabry disease.
alpha-Galactosidase
;
Angina Pectoris
;
Biopsy*
;
Chest Pain
;
Coronary Angiography
;
Creatinine
;
Diagnosis
;
Echocardiography
;
Electrocardiography
;
Fabry Disease*
;
Humans
;
Inclusion Bodies
;
Kidney
;
Lysosomes
;
Male
;
Metabolism
;
Microscopy, Electron
;
Middle Aged
;
Myocytes, Smooth Muscle
;
Neutral Glycosphingolipids
;
Proteinuria*
9.A Novel Mutation in Exon 6 in a Patient with Fabry's Disease.
Ji Hyun KIM ; Joon Kyoon LEE ; Soo Bin YIM ; Shin Kwang KHANG ; Kwang Kuk KIM
Journal of the Korean Neurological Association 1999;17(5):730-734
Fabry's disease, angiokeratoma corporis diffusum, is a rare X-linked inborn error of glycosphingolipid metabolism due to the lack of the lysosomal enzyme, alpha-galactosidase A, resulting in a progressive intracellular deposition of neutral glycosphingolipids in various tissues, including the dorsal root ganglia, autonomic nervous system, vascular endothelial, and smooth muscle cells. Clinical manifestations of Fabry's disease result predominantly from the progressive deposition of globotriaocylceramide in the nervous system or vascular endothelium, and are characterized by acro-paresthesia, angiokeratoma, corneal opacity, TIA or stroke, ischemic heart disease, and renal failure. We report a case of a 19-year-old man presenting with a 12-year history of severe distal pain, acroparesthesia, short stature, and delayed puberty. An enzymatic assay disclosed substantially diminished alpha-galactosidase A activity and an electron microscopy of the peripheral nerve showed lipid inclusions which were composed of concentrically laminated, ovoid osmiophilic bodies in the perineural fibroblast and endothelial cells. These findings are typical of Fabry's disease and additional genetic study revealed deletion mutation(TTAG) at the 6th exon of the alpha-galactosidase A gene, which is a novel mutation that had never been reported in literatures. Symptomatic treatment with carbamazepine and clonazepam was tried with a good response.
alpha-Galactosidase
;
Angiokeratoma
;
Autonomic Nervous System
;
Carbamazepine
;
Clonazepam
;
Corneal Opacity
;
Endothelial Cells
;
Endothelium, Vascular
;
Enzyme Assays
;
Exons*
;
Fabry Disease*
;
Fibroblasts
;
Ganglia, Spinal
;
Humans
;
Metabolism
;
Microscopy, Electron
;
Myocardial Ischemia
;
Myocytes, Smooth Muscle
;
Nervous System
;
Neutral Glycosphingolipids
;
Peripheral Nerves
;
Puberty, Delayed
;
Renal Insufficiency
;
Stroke
;
Young Adult